Oncolytic viruses can kill tumor cells without spreading ... Future research should focus on developing production cells compatible with the immune system to avoid potential immunological ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

More information: Shashi Gujar et al, Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy, Nature Protocols (2024). DOI: 10.1038/s41596-024-00985-1 ...

With these strategies oncolytic virus therapy companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand ...

Merck & Co’s $394 million acquisition of Viralytics has stoked interest in oncolytic viruses, a class of drugs that have been in the shadow of the checkpoint inhibitors and CAR-T therapies that ...

Advancements in oncolytic virus therapy offer new hope for cancer patients VANCOUVER, Canada - April 27, 2023 — The global oncolytic virus therapy market size is expected to reach USD 866.1 ...

One new therapy being investigated at Moffitt Cancer Center involves oncolytic viruses, which infect and ... in the breakdown of the tumor cell and production of tumor derived antigens.

The company’s market cap currently stands at $84.5m. Oncolytic virus therapies have struggled to find a sure footing in the cancer immunotherapy landscape, which is dominated by checkpoint ...

The oncolytic virus, MEM-288 will be studied in combination with Opdivo for patients with non-small cell lung cancer that progressed on standard therapy. The next phase of a clinical trial will ...